/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Empower Clinics Inc. has changed its ticker symbol to CSE: CBDT and proposes to change the Company name to CBD Therapeutics Corporation at the Company annual general meeting in June 2019.
VANCOUVER, April 10, 2019 /CNW/ - EMPOWER CLINICS INC. (CSE: EPW) (Frankfurt 8EC) ("Empower" or the "Company"), a growth oriented, diversified health and wellness company, announces that it has changed the Company's ticker symbol on the Canadian Securities Exchange (the "CSE") to CSE: CBDT. The Company also intends to seek shareholder approval for a change of name of the Company to CBD Therapeutics Corporation, and to launch a new Company website at www.empowerclinics.com
In recent weeks, the Company has been re-positioning its overall strategy to become a vertically integrated health and wellness company that connects to its 120,000 patients using a data driven focus to improve patients' lives with products, technology and health systems.
The Company believes the change of name will allow its patients, customers, shareholders, partners, team members and the investment community to have a simple and clear understanding of the Company's focus – a brand that is passionate about CBD based therapies, products and treatment options.
The Company's new ticker symbol, CSE: CBDT, supports the new brand initiative and makes it easier for the Company's followers in the investment community to associate the Company to its presence in the capital markets.
The Company has also launched a new website that is a better reflection of its health & wellness brand, providing users with a more functional and pleasant experience on desktop and mobile devices. The website will continue to evolve with new content and functionality being added over time, including educational sections, links to an e-commerce store to purchase CBD products, and a directory to the Company's growing network of clinics.
The Company intends to change the domain name for the website in conjunction with the official name change, after approval of same at the Company's next annual general and special meeting of shareholders.
"Evolving the business model and brand of the Company has been an imperative initiative for me on behalf of our shareholders, and the announcement of the Company's ticker symbol change and proposed name change reflects our path going forward," stated Steven McAuley, Empower's Chairman and CEO. "We believe the new website will allow us to drive traffic with confidence, knowing our online presence tells the story of our brand and provides users access to our extensive knowledge-base, product offerings and world-class physicians throughout our network of clinics."
Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. It is expected that Empower's proprietary product line "Sollievo" will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based products in its clinics, online and at major retailers. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.
ON BEHALF OF THE BOARD OF DIRECTORS:
Chief Executive Officer
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding the Company's proposed name change; new website; and the expected benefits of same for the Company and its stakeholders. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the proposed acquisitions and partnerships, including that: the name change may not be approved by the Company's shareholders or may not be completed; that the website may not operate as expected; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
SOURCE Empower Clinics Inc.
For further information: Investors: Steve Low, Boom Capital Markets, 647-620-5101; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-6274; Investors: Steven McAuley, CEO, [email protected], 604-789-2146